Theseus Pharmaceuticals, Inc.

CIK 1745020 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Theseus Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Feb 26, 202415-12G0001140361-24-009374
Feb 16, 2024SC 13D/A0001214659-24-003018
Feb 15, 2024EFFECT9999999995-24-000479
Feb 14, 202440001104659-24-023563
Feb 14, 202440001104659-24-023581
Feb 14, 2024POS AM0001140361-24-007880
Feb 14, 202440001104659-24-023551
Feb 14, 202440001104659-24-023556
Feb 14, 2024S-8 POS0001140361-24-007882
Feb 14, 20248-K0001104659-24-023155
Feb 14, 202440001104659-24-023571
Feb 14, 2024S-8 POS0001140361-24-007885
Feb 14, 202440001104659-24-023576
Feb 14, 202425-NSE0001354457-24-000073
Feb 14, 202440001104659-24-023559
Feb 14, 2024SC TO-T/A0001140361-24-007785
Feb 14, 2024SC 14D9/A0001104659-24-023123
Feb 13, 2024SC 13G/A0001193125-24-033273
Feb 7, 2024SC 14D9/A0001104659-24-011690
Feb 7, 2024SC TO-T/A0001140361-24-006158
Jan 30, 2024SC TO-T/A0001140361-24-004440
Jan 30, 2024SC 14D9/A0001104659-24-007988
Jan 12, 2024SC 13D/A0001214659-24-000664
Jan 10, 2024SC 14D90001104659-24-002840
Jan 9, 2024SC TO-T0001140361-24-001546